Krilogy Financial’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.23M Buy
207,145
+1,259
+0.6% +$31.8K 0.15% 113
2026
Q1
$5.21M Buy
205,886
+334
+0.2% +$8.49K 0.17% 106
2025
Q4
$5.24M Buy
205,552
+6,077
+3% +$155K 0.18% 96
2025
Q3
$5.06M Buy
199,475
+23,073
+13% +$586K 0.19% 87
2025
Q2
$4.48M Buy
176,402
+31,155
+21% +$785K 0.26% 82
2025
Q1
$3.67M Buy
145,247
+1,226
+0.9% +$30.7K 0.24% 88
2024
Q4
$3.59M Buy
144,021
+12,892
+10% +$324K 0.24% 87
2024
Q3
$3.35M Sell
131,129
-25,486
-16% -$643K 0.23% 98
2024
Q2
$3.88M Buy
156,615
+1,239
+0.8% +$30.5K 0.29% 78
2024
Q1
$3.87M Buy
155,376
+4,339
+3% +$108K 0.3% 76
2023
Q4
$3.79M Buy
151,037
+5,434
+4% +$132K 0.32% 72
2023
Q3
$3.5M Buy
145,603
+1,674
+1% +$40.7K 0.32% 74
2023
Q2
$3.53M Buy
143,929
+811
+0.6% +$20.1K 0.32% 75
2023
Q1
$3.57M Buy
143,118
+86,157
+151% +$2.13M 0.3% 75
2022
Q4
$1.38M Sell
56,961
-75,960
-57% -$1.83M 0.13% 130
2022
Q3
$3.16M Buy
132,921
+682
+0.5% +$17K 0.38% 43
2022
Q2
$3.3M Buy
132,239
+49,754
+60% +$1.26M 0.38% 43
2022
Q1
$2.17M Sell
82,485
-57,264
-41% -$1.56M 0.22% 73
2021
Q4
$3.95M Sell
139,749
-718
-0.5% -$20.4K 0.4% 47
2021
Q3
$4.02M Buy
140,467
+2,997
+2% +$86.9K 0.4% 41
2021
Q2
$3.97M Sell
137,470
-3,911
-3% -$112K 0.4% 41
2021
Q1
$4M Buy
+141,381
New +$4.09M 0.42% 37

Other funds holding IBDT

Krilogy Financial's IBDT Position: Q2 2026 in Review

Krilogy Financial increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 0.61% in Q2 2026, buying an estimated $31.8K and bringing the position to 207,145 shares worth $5.23M. The position accounts for 0.15% of the portfolio, ranked #113.

Krilogy Financial first reported a position in IBDT in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.24M in Q4 2025. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Krilogy Financial held 207,145 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $5.23M as of Q2 2026.
  • Krilogy Financial bought 1,259 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $31.8K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.15% of Krilogy Financial's portfolio in Q2 2026, its #113 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2021 and has held it in 22 quarters since.
  • Krilogy Financial's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $5.24M in Q4 2025.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.